2026년 2월 11일 · Unknown · financial · 출처 Yahoo Finance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
Astera Labs stock snapshot after recent performance
Astera Labs (ALAB) has drawn fresh attention after recent share price moves, including a 2.6% decline over the past day following gains of 26.4% over the past week.
See our latest analysis for Astera Labs.
The recent 7 day share price return of 26.4% stands out against a year to date share price return of 1.84% and a 1 year total shareholder return of 108.98%, suggesting recent momentum has picked up from a much stronger longer term base.
If this kind of AI infrastructure move has your attention, it could be a good time to see what else is shaping up in our list of 33 AI infrastructure stocks.
With Astera Labs posting a 1 year total return above 100% and trading at a discount of about 11% to the average analyst price target, investors may ask whether there is still a buying opportunity or if the market is already pricing in future growth.
Most Popular Narrative: 8.2% Undervalued
Astera Labs' most followed narrative sets a fair value of $199.15 per share, above the last close at $182.86. This frames the current valuation debate.
Expansion across multiple high growth connectivity standards (PCIe, Ethernet, CXL, and UALink), alongside deepening partnerships with leading industry players (NVIDIA, AMD, Microsoft, SAP, Alchip), positions Astera Labs to leverage the ongoing digital transformation and migration to advanced data center architectures. This reduces customer concentration risk while supporting higher gross margins from increased product mix and attach rates.
Read the complete narrative.
Curious what earnings power that kind of product mix implies, and what sort of margin profile has been baked into that fair value, the full narrative breaks down those assumptions in plain numbers.
Result: Fair Value of $199.15 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on hyperscaler AI spending and UALink adoption; slower deployments or weaker customer uptake could quickly challenge those fair value assumptions.
Find out about the key risks to this Astera Labs narrative.
Another View: Rich Sales Multiple Raises Questions
That 8.2% “undervalued” fair value sits beside a very different signal from the P/S ratio. Astera Labs trades on about 42.7x sales, compared with 18.1x for peers and 5.9x for the broader US Semiconductor group, while our fair ratio sits lower at 33.8x.
This kind of gap can mean the market is paying a heavy premium for future growth that still needs to be delivered. The question for you is whether that premium feels like justified confidence or stretched optimism.
Story Continues
See what the numbers say about this price — find out in our valuation breakdown.NasdaqGS:ALAB P/S Ratio as at Feb 2026
Build Your Own Astera Labs Narrative
If you look at these numbers and reach a different conclusion, or just want to stress test the assumptions yourself, you can build a custom view in minutes, starting with Do it your way.
A great starting point for your Astera Labs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Ready to spot your next idea?
If Astera Labs has you thinking more broadly about where to put fresh capital to work, it is worth lining up a few other focused idea lists before the next move.
Target long term compounding by scanning our list of 51 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their underlying strength. Lock in potential cashflow today by reviewing income opportunities across our 14 dividend fortresses, focused on companies with higher yielding payouts. Prioritise resilience by shortlisting companies from our 83 resilient stocks with low risk scores that stand out on balance sheet strength and lower overall risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ALAB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments